BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23865389)

  • 1. Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population.
    Hernandez D; Espejo-Gil A; Bernal-Lopez MR; Mancera-Romero J; Baca-Osorio AJ; Tinahones FJ; Armas-Padron AM; Ruiz-Esteban P; Torres A; Gomez-Huelgas R
    BMC Nephrol; 2013 Jul; 14():151. PubMed ID: 23865389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of glycated hemoglobin A
    Sinning C; Makarova N; Völzke H; Schnabel RB; Ojeda F; Dörr M; Felix SB; Koenig W; Peters A; Rathmann W; Schöttker B; Brenner H; Veronesi G; Cesana G; Brambilla P; Palosaari T; Kuulasmaa K; Njølstad I; Mathiesen EB; Wilsgaard T; Blankenberg S; Söderberg S; Ferrario MM; Thorand B
    Cardiovasc Diabetol; 2021 Nov; 20(1):223. PubMed ID: 34781939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
    Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific differences in association of glycosylated hemoglobin levels with the prevalence of cardiovascular diseases among nondiabetics: the National Health and Nutrition Examination Survey 2005-2018.
    Fan R; Li S; Xue Z; Yang R; Lyu J; He H
    BMC Cardiovasc Disord; 2024 Jun; 24(1):310. PubMed ID: 38898403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.
    Sun X; Du T; Huo R; Xu L
    Acta Diabetol; 2014; 51(3):353-60. PubMed ID: 24072380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data.
    Gordon-Dseagu VL; Mindell JS; Steptoe A; Moody A; Wardle J; Demakakos P; Shelton NJ
    PLoS One; 2015; 10(3):e0119882. PubMed ID: 25785731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.
    Goto A; Noda M; Matsushita Y; Goto M; Kato M; Isogawa A; Takahashi Y; Kurotani K; Oba S; Nanri A; Mizoue T; Yamagishi K; Yatsuya H; Saito I; Kokubo Y; Sawada N; Inoue M; Iso H; Kadowaki T; Tsugane S;
    Medicine (Baltimore); 2015 May; 94(17):e785. PubMed ID: 25929925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
    Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
    Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.
    Mata-Cases M; Franch-Nadal J; Real J; Cedenilla M; Mauricio D
    BMJ Open; 2019 Oct; 9(10):e031281. PubMed ID: 31662386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Hemoglobin A1c and Development of Cardiovascular Disease in Canadian Men and Women Without Diabetes at Baseline: A Population-Based Study of 608 474 Adults.
    Butalia S; Chu LM; Dover DC; Lau D; Yeung RO; Eurich DT; Senior P; Kaul P
    J Am Heart Assoc; 2024 May; 13(9):e031095. PubMed ID: 38639364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study.
    Junyent M; Martínez M; Borràs M; Coll B; Valdivielso JM; Vidal T; Sarró F; Roig J; Craver L; Fernández E
    BMC Nephrol; 2010 Jul; 11():14. PubMed ID: 20609210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated haemoglobin A1c is associated with low-grade albuminuria in Chinese adults.
    Huang X; Zhou Y; Xu B; Sun W; Lin L; Sun J; Xu M; Lu J; Bi Y; Wang W; Xu Y; Ning G
    BMJ Open; 2015 Aug; 5(8):e007429. PubMed ID: 26243552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.
    Rhee JJ; Zheng Y; Montez-Rath ME; Chang TI; Winkelmayer WC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28592463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism.
    Ahn CH; Min SH; Lee DH; Oh TJ; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Ha J; Sherman AS; Lim S
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2905-2913. PubMed ID: 28541544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
    Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
    J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease in octogenarians.
    Shastri S; Tighiouart H; Katz R; Rifkin DE; Fried LF; Shlipak MG; Newman AB; Sarnak MJ
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1410-7. PubMed ID: 21511839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated hemoglobin, diabetes mellitus, and cardiovascular risk in a cross-sectional study among She Chinese population.
    Lin Y; Xu Y; Chen G; Huang B; Chen Z; Yao L; Chen Z
    J Endocrinol Invest; 2012 Jan; 35(1):35-41. PubMed ID: 21613810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.